The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout
<h3>Objective</h3><p dir="ltr">This study examined the initial impact of a national BNT162b2 vaccine rollout on SARS-CoV-2 infections in Qatar.</p><h3>Methods</h3><p dir="ltr">All individuals who had completed ≥14 days of follow-up by 16...
محفوظ في:
| المؤلف الرئيسي: | Ahmed Zaqout (9538566) (author) |
|---|---|
| مؤلفون آخرون: | Joanne Daghfal (9538551) (author), Israa Alaqad (20414108) (author), Saleh A.N. Hussein (20414111) (author), Abdullah Aldushain (20414114) (author), Muna A. Almaslamani (9538548) (author), Mohammed Abukhattab (9538614) (author), Ali S. Omrani (9590116) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
حسب: Farah M. Shurrab (16324961)
منشور في: (2022) -
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
حسب: Zohaib Yousaf (9617058)
منشور في: (2022) -
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
حسب: Mohammad Altermanini (16810755)
منشور في: (2023) -
Acute myocarditis following administration of BNT162b2 vaccine
حسب: Mhd Baraa Habib (11721774)
منشور في: (2021) -
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time
حسب: Hiam Chemaitelly (439114)
منشور في: (2025)